OBJECTIVE: To present a brief synopsis of trends in the number of prescriptions and retail costs of outpatient drugs dispensed in the US between 1998 and 2003. METHODS: Data were extracted from IMS Health, the National Prescription Audit Plus and the National Disease and Therapeutic Index databases. RESULTS: In 1998, 2.7 billion outpatient prescriptions were dispensed versus 3.6 billion in 2003. This equates to a 33.3% increase over the 6-year period. Of the top 20 most dispensed drugs by volume, 40% were launched in the 1990s or 2000s. Retail costs for the total market of dispensed outpatient prescription drugs were 96.1 billion US dollars in 1998 and 196 billion US dollars in 2003, a 104% increase. Of the top 20 most dispensed drugs by retail cost, all were tradename drugs and were launched in the 1990s or 2000s. CONCLUSIONS: These data indicate a large increase in the US over a short time period in dispensed outpatient prescriptions and their associated retail costs.
OBJECTIVE: To present a brief synopsis of trends in the number of prescriptions and retail costs of outpatient drugs dispensed in the US between 1998 and 2003. METHODS: Data were extracted from IMS Health, the National Prescription Audit Plus and the National Disease and Therapeutic Index databases. RESULTS: In 1998, 2.7 billion outpatient prescriptions were dispensed versus 3.6 billion in 2003. This equates to a 33.3% increase over the 6-year period. Of the top 20 most dispensed drugs by volume, 40% were launched in the 1990s or 2000s. Retail costs for the total market of dispensed outpatient prescription drugs were 96.1 billion US dollars in 1998 and 196 billion US dollars in 2003, a 104% increase. Of the top 20 most dispensed drugs by retail cost, all were tradename drugs and were launched in the 1990s or 2000s. CONCLUSIONS: These data indicate a large increase in the US over a short time period in dispensed outpatient prescriptions and their associated retail costs.
Authors: John Hickner; Atif Zafar; Grace M Kuo; Lyle J Fagnan; Samuel N Forjuoh; Lyndee M Knox; John T Lynch; Brian Kelly Stevens; Wilson D Pace; Benjamin N Hamlin; Hilary Scherer; Brenda L Hudson; Caitlin Carroll Oppenheimer; William M Tierney Journal: Ann Fam Med Date: 2010 Nov-Dec Impact factor: 5.166
Authors: Vivian Bradaschia-Correa; Anne M Josephson; Devan Mehta; Matthew Mizrahi; Shane S Neibart; Chao Liu; Oran D Kennedy; Alesha B Castillo; Kenneth A Egol; Philipp Leucht Journal: J Bone Miner Res Date: 2017-02-27 Impact factor: 6.741
Authors: Phoebe G Thorpe; Suzanne M Gilboa; Sonia Hernandez-Diaz; Jennifer Lind; Janet D Cragan; Gerald Briggs; Sandra Kweder; Jan M Friedman; Allen A Mitchell; Margaret A Honein Journal: Pharmacoepidemiol Drug Saf Date: 2013-07-29 Impact factor: 2.890
Authors: Roberto Cardarelli; Christopher Mann; Kimberly G Fulda; Elizabeth Balyakina; Anna Espinoza; Sue Lurie Journal: BMC Fam Pract Date: 2011-12-29 Impact factor: 2.497